Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

SBC Medical Group Holdings (SBC) Non-Current Receivables (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Non-Current Receivables readings, the most recent being $4.8 million for Q4 2025.

  • On a quarterly basis, Non-Current Receivables fell 3.95% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 3.95% decrease, with the full-year FY2025 number at $4.8 million, down 3.95% from a year prior.
  • Non-Current Receivables hit $4.8 million in Q4 2025 for SBC Medical Group Holdings, down from $6.6 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $6.6 million in Q3 2024 to a low of $4.5 million in Q1 2025.
  • Median Non-Current Receivables over the past 3 years was $5.9 million (2025), compared with a mean of $5.7 million.
  • Biggest five-year swings in Non-Current Receivables: fell 22.04% in 2024 and later decreased 0.56% in 2025.
  • SBC Medical Group Holdings' Non-Current Receivables stood at $6.4 million in 2023, then fell by 22.04% to $5.0 million in 2024, then decreased by 3.95% to $4.8 million in 2025.
  • The last three reported values for Non-Current Receivables were $4.8 million (Q4 2025), $6.6 million (Q3 2025), and $5.9 million (Q2 2025) per Business Quant data.